class=”sc-29f61514-0 icZBHN”>
Studies have shown that the new R21/Matrix-M vaccine can reduce the number of symptomatic malaria cases by 75 percent within a year in affected areas, WHO chief Tedros Adhanom Ghebreyesus said in Geneva on Monday. This is not a vaccine for travelers.
Initially, three doses are required. A fourth dose a year later maintains vaccine protection. Only two years ago, the WHO recommended the first malaria vaccine, RTS,S. According to Tedros, a dose costs between two and four dollars.
About half of the world’s population lives in areas at risk of malaria, Tedros said. According to estimates, there were 247 million cases and 619,000 deaths in 2021. 95 percent of the cases occurred in Africa, and most deaths occurred in children under the age of five.
(SDA)
Source: Blick
I am Amelia James, a passionate journalist with a deep-rooted interest in current affairs. I have more than five years of experience in the media industry, working both as an author and editor for 24 Instant News. My main focus lies in international news, particularly regional conflicts and political issues around the world.
